adr_usa_0533|ANCN|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
adr_usa_0533|ANCN|Long Name|1|1|Anchiano Therapeutics Ltd Total Current Assets (Quarterly) (USD)|Anchiano Therapeutics Ltd Cash and Short Term Investments (Quarterly) (USD)|Anchiano Therapeutics Ltd Inventories (Quarterly) (USD)|Anchiano Therapeutics Ltd Net PP&E (Quarterly) (USD)|Anchiano Therapeutics Ltd Goodwill and Intangibles (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Liabilities (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Current Liabilities (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Long Term Liabilities (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Deposits (Quarterly) (USD)|Anchiano Therapeutics Ltd Book Value (Quarterly) (USD)|Anchiano Therapeutics Ltd Retained Earnings (Quarterly) (USD)|Anchiano Therapeutics Ltd Treasury Stock (Quarterly) (USD)|Anchiano Therapeutics Ltd EV to Revenues|Anchiano Therapeutics Ltd EV to Earnings|Anchiano Therapeutics Ltd EV to Free Cash Flow|Anchiano Therapeutics Ltd EV to Assets (Quarterly)|Anchiano Therapeutics Ltd PS Ratio|Anchiano Therapeutics Ltd PE Ratio|Anchiano Therapeutics Ltd Price to Book Value|Anchiano Therapeutics Ltd PEG Ratio|Anchiano Therapeutics Ltd Debt to Equity Ratio|Anchiano Therapeutics Ltd Dividend Yield|Anchiano Therapeutics Ltd Shareholder Yield (TTM)|Anchiano Therapeutics Ltd Percent of Shares Outstanding Short|Anchiano Therapeutics Ltd Total Receivables (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Payables (Quarterly) (USD)|Anchiano Therapeutics Ltd Total Capital Stock (Quarterly) (USD)|Anchiano Therapeutics Ltd Return on Invested Capital|Anchiano Therapeutics Ltd Quality Ratio Score|Anchiano Therapeutics Ltd Momentum Score|Anchiano Therapeutics Ltd Beta (1Y)|Anchiano Therapeutics Ltd Sustainable Growth Rate (TTM)|Anchiano Therapeutics Ltd Institutional Investor Ownership Percentage|Anchiano Therapeutics Ltd Average Diluted Shares Outstanding (Quarterly)|Anchiano Therapeutics Ltd Total Employees (Annual)|Anchiano Therapeutics Ltd EPS Diluted (Quarterly) (USD)|Anchiano Therapeutics Ltd Shares Outstanding|Anchiano Therapeutics Ltd Repurchase of Capital Stock (Quarterly) (USD)|Anchiano Therapeutics Ltd Ordinary Shares Number (Quarterly)|Anchiano Therapeutics Ltd Payout Ratio|Anchiano Therapeutics Ltd Quick Ratio (Quarterly)|Anchiano Therapeutics Ltd Normalized Diluted EPS (Quarterly) (USD)|Anchiano Therapeutics Ltd Stock Buybacks (Quarterly) (USD)|Anchiano Therapeutics Ltd Effective Tax Rate (TTM)|Anchiano Therapeutics Ltd Return on Equity|Anchiano Therapeutics Ltd Net Income (TTM) (USD)|Anchiano Therapeutics Ltd Revenue (TTM) (USD)|Anchiano Therapeutics Ltd Dividend Per Share (Quarterly) (USD)|Anchiano Therapeutics Ltd Revenue (Quarterly) (USD)|Anchiano Therapeutics Ltd Gross Profit (Quarterly) (USD)|Anchiano Therapeutics Ltd SG&A Expense (Quarterly) (USD)|Anchiano Therapeutics Ltd Pre-Tax Income (Quarterly) (USD)|Anchiano Therapeutics Ltd Net Income (Quarterly) (USD)|Anchiano Therapeutics Ltd Net Interest Income (Quarterly) (USD)|Anchiano Therapeutics Ltd Price (USD)|Anchiano Therapeutics Ltd Total Return Price (USD)|Anchiano Therapeutics Ltd Enterprise Value (USD)|Anchiano Therapeutics Ltd 30-Day Average Daily Volume|Anchiano Therapeutics Ltd 1 Year Price Returns (Daily)
adr_usa_0533|ANCN|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
adr_usa_0533|ANCN||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
adr_usa_0533|ANCN||5|5|91.2142857143|91.2142857143|0|91.2142857143|0|91.2142857143|91.2142857143|91.2142857143|0|91.2142857143|91.2142857143|0|0|0|1.44289044289|0|0|0|1.44289044289|0|0|1.44289044289|0|15.2051282051|91.25|91.2142857143|91.2142857143|0|0|30.5|30.5714285714|0|0|91.2941176471|365|91.2941176471|164|0|91.2142857143|0|0|91.2941176471|91.3333333333|91.25|0|91.2142857143|0|0|0|0|91.2941176471|91.2941176471|91.2941176471|91.2941176471|1.44289044289|1.44289044289|1.44289044289|1.4425|1.43502824859
adr_usa_0533|ANCN||6|6|14|14|0|14|0|14|14|14|0|14|14|0|0|0|429|0|0|0|429|0|0|429|0|39|12|14|14|0|0|6|7|0|0|17|1|17|16|0|14|0|0|17|15|8|0|14|0|0|0|0|17|17|17|17|429|429|429|400|177
adr_usa_0533|ANCN||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
adr_usa_0533|ANCN|201305|201303|201303|||||||||||||||||||||||||||||||||||||22.9509||||||||||||||||||||||
adr_usa_0533|ANCN|201603|201603|201603||||||||||||||||||||||||||||||||||9.7784||-0.0794||||||-0.0794|0||||||||0.2386|-0.7919|-0.7919|-0.0122|||||
adr_usa_0533|ANCN|201606|201606|201606||||||||||||||||||||||||||||||||||9.8234||-0.1167||||||-0.1167|-0.5311||||||||0.6481|-1.0869|-1.1419|0.0083|||||
adr_usa_0533|ANCN|201609|201609|201609||||||||||||||||||||||||||||||||||10.184||-0.1465||||||-0.1465|-5.3046||||||||0.6299|-1.3901|-1.4444|-0.0578|||||
adr_usa_0533|ANCN|201612|201612|201612|5.4297|4.5625||0.2134||2.3577|2.3577|0||3.2946|-52.7284||||||||||||||0.1391|2.0738|1.9238|||||||14.7994||-0.0897|14.7994||73.997|||-0.0897|-0.6673|-2.9652||-4.7056|||||0.7225|-1.3012|-1.3274|0.0558|||||
adr_usa_0533|ANCN|201703|201703|201703|4.269|3.4546||0.2161||3.1554|3.1554|0||1.3413|-58.3159||||||||||||||0.8144|2.944|2.0423|||||||14.7994||-0.1518|||73.997|||-0.1518|0|-3.1934||-6.2519|||||0.7998|-2.2802|-2.3382|-0.2004|||||
adr_usa_0533|ANCN|201706|201706|201706|5.4247|5.0405||0.2139||2.741|2.741|0||2.9068|-64.3314||||||||||||||0.3842|2.5274|2.7562|||||||1.8886||-2.007||||||-2.007|-5.934|-2.7573||-8.8583|||||0.7546|-3.6491|-3.7483|0.0229|||||
adr_usa_0533|ANCN|201709|201709|201709|3.7683|3.3351||0.2232||2.8824|2.8824|0||1.1188|-65.5041||||||||||||||0.4332|2.7181|2.7235|||||||1.9078||-1|||96.131|||-1|0.269|-2.6418||-9.3389|||||0.777|-1.868|-1.925|0.034|||||
adr_usa_0533|ANCN|201712|201712|201712|1.854|1.454||0.219||2.696|2.696|0||-0.609|-62.876||||||||||||||0.088|0.16|0|||||||1.9304||-1|19.2262||96.131|||-1|0|-3.3965||-9.9595|||||0.875|-1.835|-1.948|0.134|||||
adr_usa_0533|ANCN|201803|201803|201803|1.3156|0.6689||0.2463||5.647|5.647|0||-3.9107|-71.2904||||||||||||||0.6467|5.4978|2.7375|||||||19.2262||-0.1841|||96.131|||-0.1841||-3.0585||-11.1603|||||0.926|-3.477|-3.539|-0.076|||||
adr_usa_0533|ANCN|201806|201806|201806|20.8514|19.4887||0.2712||18.7443|12.2279|6.5164||2.5884|-73.5844||||||||||||||1.3627|6.3406|0|||||||1.9358||-2.75|||96.131|||-2.75|-10.911|-4.6263||-12.71|||||2.287|-4.968|-5.298|-0.806|||||
adr_usa_0533|ANCN|201808|201806|201806|||||||||||||||||||||||||||||||||||||3.1151||||||||||||||||||||||
adr_usa_0533|ANCN|201809|201809|201809|13.921|10.912||0.347||14.97|9.96|5.01||0.233|-74.346||||||||||||||3.009|2.416|0|||||||3.1148||-0.85|||96.131|||-0.85|0|-4.4609||-13.418|||||1.133|-2.565|-2.633|-0.06|||||
adr_usa_0533|ANCN|201812|201812|201812|10.92|7.517||0.385||2.956|2.746|0.21||9.805|-78.307||||||||||||||3.403|0.396|0|||||||3.1076|19|-0.55|3.1151||15.5757|||-0.55|10.911|-2.2604||-13.798|||||1.175|-2.483|-2.328|0.958|||||
adr_usa_0533|ANCN|201902|201812|201812|||||||||||||||-3.5912||||6.054|||0||0.1524|||||||||||||7.4199||||||||||||||||||8|8|51.8422||
adr_usa_0533|ANCN|201903|201903|201903|33.354|||||10.432|4.75|5.682||26.348|||||-2.9718||||5.1421|||0||0.4002||||||||||5.2675||-1.9|7.4199||37.0994|||-1.9||||-20.172|||||1.291|-9.913|-9.913|-4.487|6.795|6.795|42.9012|17908.7333|
adr_usa_0533|ANCN|201904|201903|201903|||||||||||||||-2.8899||||1.6404|||0||0.1782|||||||||||||||||||||||||||||||5.825|5.825|43.2209|10480.8667|
adr_usa_0533|ANCN|201905|201903|201903|||||||||||||||-2.4806||||1.4081|||0||0.1007|||||||||||||||||||||||||||||||5|5|37.0995|4981.3|
adr_usa_0533|ANCN|201906|201906|201906|27.895|27.01||1.993||6.173|3.239|2.934||24.883|-96.404||||-2.2226||||1.2616|||0||0.1465|0.885|2.001|0|||||||7.4199||-0.6|||15.5757|||-0.6||||-19.313|||||1.962|-4.439|-4.439|0.099|4.48|4.48|33.2412|5268.6|
adr_usa_0533|ANCN|201907|201906|201906|||||||||||||||0.2948||||0.8856|||0||0.0354|||||||||||||7.4199||||||||||||||||||2.97|2.97|-4.9729|9972.8667|
adr_usa_0533|ANCN|201908|201906|201906|||||||||||||||0.5147||||0.7365|||0||0.0397|||||||||||||||||||||||||||||||2.47|2.47|-8.6828|32094.7333|
adr_usa_0533|ANCN|201909|201909|201909|24.478|23.242||1.936|3.346|21.571|15.313|6.258||9.286|-112.322||||0.4556||||1.8372|||0||0.0933|1.236|4.675|0|||||||7.4198||-2.15|||15.5757|||-2.15|-30.5|||-32.598|||||1.664|-16.351|-15.918|-12.454|2.2993|2.2993|-6.1814|56249.5|
adr_usa_0533|ANCN|201910|201909|201909|||||||||||||||0.4497||||1.8458|||0||0.0812|||||||||||||||||||||||||||||||2.31|2.31|-6.102|30934.2667|
adr_usa_0533|ANCN|201911|201909|201909|||||||||||||||0.9419||||1.1266|||0||0.0557|||||||||||||||||||||||||||||||1.41|1.41|-12.7799|30836.4|
adr_usa_0533|ANCN|201912|201912|201912|18.211|17.575||1.357||4.846|4.121|0.725||14.909|-105.431||||0.4342||||0.6968|||0||0.1093|0.408|0.875|0|||||||7.4262|16|1.45|7.4199||37.0994|||1.45|30.5|||-21.219|||||1.434|9.205|9.051|22.939|1.4|1.4|-7.1871|27000.9667|
adr_usa_0533|ANCN|202001|201912|201912|||||||||||||||0.488||||0.637|||0||0.1957|||||||||||||||||||||||||||||||1.28|1.28|-8.0775|46877.5667|
adr_usa_0533|ANCN|202002|201912|201912|||||||||||||||0.659||||0.4472|||0||0.1395|||||||0.6736||||||7.4199||||||||||||||||||0.8985|0.8985|-10.9082|34848.8|-88.7688
adr_usa_0533|ANCN|202003|202003|202003|14.677|14.009||0.46||3.623|3.471|0.152||11.56|-108.966||||0.4831||||0.5045|||0||0.1816||0.602|0|||1|0.2754|||7.4199||-0.5|7.4199||37.0994|||-0.4097||||-14.841|||||1.825|-3.535|-3.535|0.01|0.786|0.786|-8.177|27629.4667|-88.4327
adr_usa_0533|ANCN|202004|202003|202003|||||||||||||||0.4359||||0.5736|||0||0.1937||||||1|0.9052||||||||||||||||||||||||0.8936|0.8936|-7.3786|23652|-84.6592
adr_usa_0533|ANCN|202005|202003|202003|||||||||||||||0.3455||||0.706|||0||0.0675||||||1|1.227||||||7.4199||||||||||||||||||1.1|1.1|-5.8471|50783.8667|-77.5967
adr_usa_0533|ANCN|202006|202006|202006|9.672|8.824||0.293||1.859|1.751|0.108||8.157|-112.447||||-0.0728||||1.2462|||0||0.2395||0.974|0|||1|1.4254|||7.4199||-0.45|7.4199||37.0994|||-0.45||||-13.883|||||2.176|-3.481|-3.481|0.002|1.37|1.37|1.3413|93399.1|-69.4196
adr_usa_0533|ANCN|202007|202006|202006|||||||||||||||0.0894||||0.8798|||0||0.1457||||||1|1.1586||||||7.4199||||||||||||||||||0.9672|0.9672|-1.6475|107610.6|-67.4343
adr_usa_0533|ANCN|202008|202006|202006|||||||||||||||0.0848||||0.8902|||0||0.1131||||||1|1.1206||||||||||||||||||||||||0.9786|0.9786|-1.5629|101862.9|-60.3806
adr_usa_0533|ANCN|202009|202009|202009|||||||||||||||0.0198||||1.037|||0||0.3027||||||2|0.8364||||||||||||||||||||||||1.14|1.14|-0.3653|54246.0333|-50.4197
adr_usa_0533|ANCN|202010|202009|202009|||||||||||||||0.04||||0.9915|||0|||||||||||||||||||||||||||||||||1.09|1.09|-0.7363|553932.8|-50